4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000899243-22-007519
Options or other derivatives
- Chief Executive Officer acquired 630,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Schatzman Randall C Chief Executive Officer | 2022-02-18 | Grant or award · Stock Option (Right to Buy) | +630,000 | 630,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…